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Abstract
Actinomycetes are the potential sources of novel metabolites, therapeutic com‐
pounds, enzymes, and other chemicals. Among them, the applications of halophilic
actinomycetes toward the medically and industrially important metabolites and en‐
zymes are gaining increasing attention by the scientific community. A large number
of novel compounds and enzymes from halophilic actinomycetes have been isolat‐
ed and characterized from various geographic regions around the world. In this
chapter, occurrence, characterization, halotolerant mechanisms, medical impor‐
tance, metabolites, enzymes, and industrial applications of halophilic actinomycetes
are discussed. Halophilic actinomycetes may also serve as good models for the pro‐
duction of important metabolites and enzymes with respect to stress response.
Keywords: Halophilic actinomycetes, occurrence, metabolites, enzymes, applica‐
tions
1. Introduction
Actinomycetes are the most valuable microorganisms for the production and synthesis of
economically important therapeutic compounds and antibiotics. They are the source for the
production of about more than 50% of discovered bioactive compounds, including antitu‐
mor agents, antibiotics, enzymes, and immunosuppressive agents [1, 2]. Most of these bioac‐
tive secondary metabolites were isolated from terrestrial actinomycetes; however, in recent
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years, the rate of discovery of new bioactive compounds has decreased. Hence, it is crucial
that new groups of actinomycetes from unexplored or underexploited environments should
be exploited optimally to obtain novel bioactive secondary metabolites [3]. Unexplored re‐
gions of high salt deposited areas, conditions closely related to the marine water regions, re‐
gions with increased levels of pH, and low oxygen were the suitable places to isolate
halophilic actinomycetes. Actinomycetes recovered from halophilic and unexplored regions
attracted the interest of researchers because of their applications in the medical and biotech‐
nological fields [4]. This chapter deals with the characterization methods for the identifica‐
tion of halophilic actinomycetes and their applications
2. Occurrence of halophilic actinomycetes
Marine sediment, soil, water, contaminated regions on the seashore, salt lakes, saline soils,
alkaline–saline habitats, brines, and other regions are good sources for the selection of novel
halophilic actinomycetes. Recent literature claimed that the saline regions contain many sig‐
nificant uncultured actinomycetes [5]. In particular, actinomycetes such as Streptomyces phar‐
mamarensis, Prauserella halophila, Pseudonocardia sp., Salinispora arenicola, Aeromicrobium sp.,
Micromonospora sp., Marinactinospora thermotolerans, Microbacterium sp., Nocardiopsis xinjian‐
gensis, Salinibacterium sp., Salinactinospora qingdaonensis, Rhodococcus sp., Actinomadura sp.,
Saccharopolyspora sp., Streptosporangium sp., Actinopolyspora algeriensis, Marinophilus sp.,
Streptomonospora halophila, Verrucosispora sp., Gordonia sp., and Nonomuraea species were re‐
covered and characterized from hypersaline regions [6–10]. Also, it was quoted that the
characterization of novel halotolerant actinomycetes was specific with respect to their mor‐
phological, biochemical, physiological, and molecular level identification.
3. Identification and characterization of halophilic actinomycetes
In general, different pretreatment methods such as incorporation of specific antibiotics were
used to prevent the growth of bacteria and fungi, and alteration in the composition of the
cultivation medium was specific for the isolation of rare actinomycetes. However, humic
acid and different concentrations of vitamin agar medium were the best base for the selec‐
tion of rare halophilic actinomycetes. Humic acid strengthens the morphological identifica‐
tion and characterizes the spore chain of the actinomycetes by preventing the production of
diffusible pigments in the cultivation medium. A substantial part of the microbes in envi‐
ronmental samples are not cultivable and therefore cannot be identified by methods based
on culturing of the strains. However, protocols based on molecular techniques are not de‐
pendent on the viability of the microbes, and molecular methods for the amplification of
specific genes such as 16S rRNA and rec A can be designed to work at different levels of spe‐
cificity for the detection of whole groups of actinomycetes. Polymerase chain reaction
(PCR)-based methods for the detection and identification of microbes are widely used in the
cultivation of industrially important microbes [11]. Applications in environmental microbi‐
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ology, especially in the soil environment, are also increasing [12]. With currently used culti‐
vation methods, only a small part of the halophilic actinomycetes diversity is detected. The
cultivability values ranged from 0.001% to 15%, depending on the cultivation area and the
method of cultivation medium [13]. On the other hand, PCR amplification of 16S rRNA
genes from environmental samples has revealed that 7–64% of the amplified sequences ori‐
ginated from uncultured actinomycetes [14]. Comparisons of the amounts of total and culti‐
vable microbes in the indoor environment have shown that the cultivable part of the
microbial community ranges from 1% to 10% [15]. Therefore, careful attention must be paid
in the identification of the rare halophilic actinomycetes.
4. Halotolerance mechanism
Halophilic actinomycetes require higher concentrations of salt for their growth and are clas‐
sified into moderate (15% NaCl) and extreme (30% NaCl) halophiles. They survive through
two mechanisms – “high-salt-in” and “low-salt, organic-solutes-in” – for the protection of
intercellular proteins in the presence of salts similar to potassium chloride and production
of organic acids, which will directly alter the intracellular enzyme levels. To adjust to the hy‐
per-salt conditions, halophilic cell membranes are composed of main adaptive systems that
block NaCl from penetrating into the cells, such as the accumulation of inorganic salts and
the water-soluble low-molecular-weight organic compounds. Inorganic salts in the form of
(Na+, K+, Cl-) are mainly involved in adjusting the osmotic potentials, and the organic salts in
the form of small solutes or electrolytes are concerned with the balance of the intracellular
salt levels [16]. These two mechanisms are mainly involved in the maintenance of the cell
structure; therefore, the cells thrive in stress conditions such as high salt [17].
5. Importance of halophilic actinomycetes
Actinomycetes identified in the halophilic regions such as salt lakes, salterns, solar salts, and
subsurface salt formation have to cope up with the osmotic stress were an infinite pool of
novel chemical molecules with increasing importance for several biotechnological applica‐
tions in different fields. Traditionally, halophiles have been used in the food and nutraceuti‐
cal industries for the fermentation of soy and fish sauces and β-carotene production; also
they have been recently used in many novel and unique molecules such as compatible sol‐
utes, biopolymers or carotenoids, enzymes, biodegradable plastics, biosurfactants, bioemul‐
sifiers, and bacteriorhodopsins for molecular biotechnology applications [18, 19]. Among the
valuable products, enzymes obtained from these organisms, mainly involved in the process‐
ing of food, act as a catalyst in the bioremediation process and other biosynthetic processes.
In addition to the enzymes, highly sensitive chromoproteins derived from halophiles act as
a biocomputing and light-sensitive neurological probe for the treatment of blindness [20].
Ectoine and hydroxyectoine obtained from the halophilic actinomycetes are commercially
used as protective and stabilizing agents for mammalian cells [21]. Ectoine derived from
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Halomonas boliviensis fermentation reduces the DNA lesions induced by visible and UVA-
visible lights. Besides, halophiles attracted many researchers for the development of sustain‐
able energy production to minimize the effects of global warming. Because halophiles have
superior qualities such as high tolerance levels of the enzymes toward salts and tempera‐
tures, stability in the presence of organic solvents, secretion of therapeutic compounds, and
antimicrobial properties, in many applications, studies of halophilic bacteria have devel‐
oped rapidly and significant advances have been made recently [22].
6. Metabolites produced by halophilic actinomycetes
In the last two decades, halophilic actinomycetes have gained significant importance as a
new, promising source for novel bioactive compounds that can be used for drug develop‐
ment. Halophilic actinomycetes may produce a variety of bioactive compounds, which have
a wide range of biological activities, including antibacterial, antifungal, antiviral, and other
bioactive compounds [23]. The vast majority of bioactive compounds that isolated from hal‐
ophilic actinomycetes are derived from the genus Streptomyces, whose species are very wide‐
ly distributed in nature and cover around 80% of the total produced antibiotics [24].
7. Antibacterial
An antibacterial is an agent that may either inhibit the bacterial growth or kill the bacteria.
The urgent need to find novel antibacterial agents has increased during the last decade ow‐
ing to the increase of emerging multidrug-resistant bacteria. The discovery of novel antibiot‐
ics that have a potent effect against resistant pathogenic bacteria is an important aspect of
antibiotics research today. The diversity of natural products makes it one of the most impor‐
tant sources for novel structures, which have been noticed to possess useful biological activi‐
ties. Several studies are oriented toward the isolation of new actinomycetes from different
habitats in the context of the search for novel antibiotics from new sources representing one
of these habitats [25].
Generally, the antibacterial activity of halophilic actinomycetes from marine environments
is extensively studied. Nevertheless, the exploitation of halophilic actinomycetes as a source
for the discovery of novel antibiotics is still at an early stage, despite that numerous novel
antibacterial compounds were isolated during the last few years (Table 1). Arenimycin (Fig.
1a) is a novel antibacterial compound isolated from the extreme halophilic actinomycete Sal‐
inispora arenicola. This compound was classified as a new antibiotic based on the novel struc‐
ture, which belongs to the benzo [α] naphthacene quinone class of antibiotics. Arenimycin
has proven to show a potent antibacterial activity against a panel of drug-resistant human
pathogens such as rifampin- and methicillin-resistant Staphylococcus aureus. Arenimycin is a
representative of the first report of this class of antibiotics from marine actinomycetes [26].
Abyssomicin C (Fig. 1b) is another example for novel antibacterial compounds extracted
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from the halophilic actinomycete Verrucosispora sp. [27]. Abyssomicin C was derived with
other two novel structures that belong to the polycyclic polyketides abyssomicin B and
abyssomicin D. Among these three compounds, abyssomicin C strongly exhibits antibacteri‐
al activity against Gram-positive bacteria, including multiresistant clinical isolates of Staphy‐
lococcus aureus. The mode of action of this new antibiotic is based on the inhibition of para-
aminobenzoic acid biosynthesis resulting in the inhibition of the folic acid biosynthesis
pathway.
 
 
 
 
 
 
 
                             
 
 
 
 
 
 
 
 
 
                                a. Arenimycin                                                                 b. Abyssomicin C       
 
Figure 1. Chemical structure of some novel antibacterial compounds produced by halophilic actinomycetes [26, 27].
Compound Source
1,4-Dihydroxy-2-(3-hydroxybutyl)-9,10-anthraquinone 9,10-anthrac Streptomyces sp.
1-Hydroxy-1-norresistomycin Streptomyces chinaensis
Abyssomicins Verrucosispora sp.
Arenimycin Salinispora arenicola
Bisanthraquinone Streptomyces sp.
Bonactin Streptomyces sp.
Caboxamycin Streptomyces sp.
Chloro-dihydroquinones Streptomyces sp.
Diazepinomicin Micromonospora sp.
Essramycin Streptomyces sp.
Frigocyclinone Streptomyces griseus
Glaciapyrroles Streptomyces sp.
Gutingimycin Streptomyces sp.
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Compound Source
Helquinoline Janibacter limosus
Himalomycins Streptomyces sp.
Lajollamycin Streptomyces nodosus
Lincomycin Streptomyces lincolnensis
Lynamicins Marinispora sp.
Marinomycins Marinispora sp.
Marinopyrroles Streptomyces sp.
Proximicins Verrucosispora sp.
Resistoflavin methyl ether) Streptomyces sp.
Tirandamycins Streptomyces sp.
TP-1161 Nocardiopsis sp.
The listed compounds and the strains were obtained from the report of Subramani and Aalbersberg, (2012) [36].
Table 1. Novel antibacterial compounds produced by halophilic actinomycetes
8. Antifungal
The number of antifungal agents available for controlling fungal infections is still limited in
comparison to antibacterial agents, and their use is still risky owing to toxicity and side ef‐
fects [28]. Therefore, studies are still being conducted to isolate and identify novel antifun‐
gals that are potentially effective against pathogenic fungi [23]. Halophilic actinomycetes
from marine environments are useful biological tools for the discovery of novel antifungal
substances against fungi. Few studies reported the isolation of antifungal agents from halo‐
philic actinomycetes. Streptomyces is the main source for antifungal agents (Table 2) which
have been isolated from marine habitats.
Compound Source
Azalomycin F4a 2-ethylpentyl ester Streptomyces sp.
Bonactin Streptomyces sp.
Chandrananimycin Actinomadura sp.
Daryamides Streptomyces sp.
N-(2-hydroxyphenyl)-2-phenazinamine (NHP) Nocardia dassonvillei
The listed compounds and the strains were obtained from the report of Subramani and Aalbersberg, (2012) [36].
Table 2. Novel antifungal agents produced by halophilic actinomycetes
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Chandrananimycin A (Fig. 2a) is a novel antifungal substance produced by marine Actino‐
madura sp. strain M048. Chandrananimycin A exhibited strong, effective antifungal activity
against Mucor miehei. It exhibits other biological activities as an antibacterial, anticancer, and
antialgal agent against the microalgae [29]. N-(2-hydroxyphenyl)-2-phenazinamine (NHP)
(Fig. 2b) is a new antibiotic produced by halophilic actinomycetes isolated from the sedi‐
ment sample Nocardia dassonvillei collected from the Arctic Ocean [30]. The new antibiotics
possess potent antifungal activity against Candida albicans, with an MIC of 64 µg /ml.
 
       a. Chandrananimycin A                        b. N‐(2‐hydroxyphenyl)‐2‐phenazinamine (NHP) 
 
Figure 2. Chemical structure of novel antifungal isolated from halophilic actinomycetes [30].
9. Antiviral
Natural products represent the main source for discovering new/novel chemical structures
that are used for the treatment of infections. The vast majority of secondary metabolites pro‐
duced by microbes that have been developed for controlling microbial infections are direct‐
ed against bacterial and fungal infections but not against viral infections. To date, antiviral
agents have been isolated from natural products that are limited, and the studies in this field
are few [31]. The antiviral agents available commercially in pharmacological markets are
over 40 compounds, including those being tested as promising antiviral agents or alterna‐
tive antiviral medicines [32]. Potential substances that possess antiviral activity have been
isolated from halophilic microorganisms from marine environments. EPS-1 and EPS-2 are
antiviral agents produced by Bacillus licheniformis and Geobacillus thermodenitrificans, respec‐
tively, targeting the replication of herpes simplex virus type 2 (HSV-2) [33]. Cyanovirin-N
was obtained from the halophilic cyanobacteria Nostoc ellipsosporum. Cyanovirin-N has anti‐
viral activity against HIV-1 and HIV-2 by targeting the replication [34]. However, halophilic
actinomycetes produce several bioactive compounds, the compounds derived from halo‐
philic actinomycetes as antiviral agents are limited. Antimycin A is an antiviral substance
produced by Streptomyces kaviengensis isolated from marine sediments collected from the
coast of New Ireland, Papua New Guinea. Antimycin A has potent antiviral activity against
western equine encephalitis virus and a wide range of RNA viruses in cultured cells, includ‐
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ing members of the Togaviridae, Flaviviridae, Bunyaviridae, Picornaviridae, and Paramyxoviridae
families. Benzastatin C (Fig. 3) is a 3-chloro-tetrahydroquinolone alkaloid extracted from the
halophilic actinomycete Streptomyces nitrosporeus [35]. This compound exhibited antiviral ac‐
tivity against herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and
vesicular stomatitis virus (VSV), respectively, in a dose-dependent manner with EC50 val‐
ues of 1.92, 0.53, and 1.99 µg/mL.
Figure 3. Chemical structure of benzastatin C produced by Streptomyces nitrosporeus [35].
10. Therapeutic compounds
Diseases constitute a significant threat in the life of humans; over 30,000 diseases have been
described clinically. Nevertheless, only less than one third of these can be treated [36]. There
is an urgent need to obtain new therapeutic agents to cover this medical requirement. Natu‐
ral products are able to fulfill medical needs through the discovery of novel therapeutic
compounds [37]. In this regard, investigations on halophilic actinomycetes during recent
years have led to the development of numerous isolated therapeutic substances (Table 3),
including anticancer, antitumor, anti-inflammatory, antioxidant, and antimalarial substan‐
ces [38]. Salinosporamide A (Fig. 4a) is a novel anticancer substance isolated from the ma‐
rine actinomycete Salinispora tropica. Its chemical structure is bicyclic beta-lactone gamma-
lactam. The mode of action of salinosporamide A is the inhibition of proteasome, which
leads to induced apoptosis in multiple myeloma cells [39]. Nereus Pharmaceuticals, Inc., has
developed salinosporamide A under the name NPI-0052 for the treatment of cancer in hu‐
mans, which represents the first clinical anticancer agent candidate for the treatment of can‐
cer produced by halophilic actinomycetes [36]. Lodopyridone (Fig. 4b) is an anticancer agent
obtained from the marine actinomycete Saccharomonospora sp. [40]. Lodopyridone exhibited
anticancer activity against the human colon adenocarcinoma cell line HCT-116 with an IC50
of 3.6 µM. Cyclomarin A is a novel anti-inflammatory agent isolated from halophilic Strepto‐
myces sp. It is a cyclic heptapeptide and possesses potent anti-inflammatory activity in both
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in vivo and in vitro assays. Trioxacarcin is a new antimalarial substance isolated from ma‐
rine Streptomyces sp. [41]. Trioxacarcin has been tested for antimalarial activity. Results
showed extremely high antiplasmodial activity against the pathogen of malaria in compari‐
son to the artemisinin drug, the most effective drug against malaria. Actinosporins C and D
are novel antioxidants produced by the sponge-associated actinomycete Actinokineospora sp.
strain EG49 isolated from the marine sponge Spheciospongia vagabunda [42]. Actinosporins C
and D showed (at 1.25 µM) a significant antioxidant and protective capacity from the ge‐
nomic damage induced by hydrogen peroxide in the human promyelocytic (HL-60) cell line.
Compound Source
Biological activity: anticancer
1-Hydroxy-1-norresistomycin Streptomyces chinaensis
3,6-Disubstituted indoles Streptomyces sp.
Caprolactones Streptomyces sp.
Chinikomycins Streptomyces sp.
IB-00208 Actinomadura sp.
Lodopyridone Saccharomonospora sp.
Marinomycins A-D Marinispora
Mechercharmycins Thermoactinomyces sp.
Salinosporamide A Salinispora tropica
ZHD-0501 Actinomadura sp.
Biological activity: antitumor
1,8-Dihydroxy-2-ethyl-3-
methylanthraquinone)
Streptomyces sp.
Arenicolides Salinispora arenicola
Aureolic acid Streptomyces sp.
Aureoverticillactam Streptomyces aureoverticillatus
Butenolides Streptoverticillium luteoverticillatum
Chalcomycin Streptomyces sp.
Daryamides Streptomyces sp.
Elaiomycins B and C Streptomyces sp.
Glyciapyrroles Streptomyces sp.
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Compound Source
Mitomycin C Streptomyces lavendulae
Piericidins Streptomyces sp.
Staurosporinone Streptomyces sp.
Streptokordin Streptomyces sp.
Biological activity: anti-inflammatory
Cyclomarins Streptomyces sp.
Salinispora
Arenicola
Salinamides A and B Streptomyces sp.
Biological activity: antioxidant
Dermacozines A-G Dermacoccus
Actinosporins C-D Actinokineospora sp.
Biological activity: antimalarial
Trioxacarcin A, B, and C Streptomyces ochraceus
Streptomyces bottropensis
The listed compounds and the strains were obtained from the report of Subramani and Aalbersberg, (2012) [36].
Table 3. Novel therapeutic substances isolated form halophilic actinomycetes
  a. Salinosporamide A            b. Lodopyridone 
                   

Figure 4. Chemical structure of some therapeutic compounds produced by halophilic actinomycetes [5].
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11. Biodegradable chemicals
Saline environments, particularly waters and soils, are always exposed to contamination by
heavy metals or other toxic chemical substances due to anthropogenic activities [43]. The
degradation of different substances in the environment is a continuous process due to the
continued activities of microorganisms. Microorganisms degrade toxic compounds to non‐
toxic materials such as H2O, CO2, or other inorganic compounds [44]. Halophiles play a sig‐
nificant role in the biodegradation of the materials that contaminate marine environments.
Actinomycetes have been reported to be one of those microorganisms that contribute in the
degradation of organic compounds in the nature and play a role in the mineralization of or‐
ganic matter [36]. Petroleum substances constitute one of the materials that contaminate ma‐
rine habitats [45]. In a study carried out on oil-utilizing halophilic bacteria, results of
phylogenetic studies showed that 30% of all isolates belonged to actinomycetes [46]. Ex‐
tremely halophilic actinomycetes, Streptomyces albiaxialis, were reported to be able to grow in
extreme environment by using crude oil as the sole carbon source in a salinity level up to
10% NaCl. Halophilic actinomycetes isolated from the oil-polluted soil in Russia were iden‐
tified as Rhodococcus erythropolis. It was grown in a medium containing crude oil as a unique
source of carbon. Results showed degradation of n-alkanes and iso-alkanes with chain
lengths of C11–C30 and C14–C18 [47]. A new extremely halophilic actinomycete strain that be‐
longs to Actinopolyspora sp. was isolated from saline and arid surroundings of an oil field in
the Sultanate of Oman. This strain exhibited the capability of degrading alkanes up to C15
and, at a slower rate, up to C25 [48].
12. Industrially important enzymes
The extracellular enzymes produced by halophilic actinomycetes have significant advantag‐
es in biotechnological applications, such as biosynthetic processes, environmental bioreme‐
diation, and food processing. Most of the enzymes are active and stable at high
temperatures and pH values and have ionic strength in the presence of organic solvents [49].
They have the capability of secreting extracellular enzymes such as lipase, DNase, protease,
esterase, pullulanase, galactosidase, nuclease, xylanase, inulinase, cellulose, pectinase, gelat‐
inase, alpha-glucosidase, beta-glucosidase, alpha-mannosidase, beta-mannosidase, chitinas‐
es, xylose isomerases, fructokinases, ribokinases, etc., which exhibit higher activity in
alkaline pH and stability in high concentrations of organic solvents in their environment
which have been reported in the last few years [50–52]. Among the industrially important
enzymes, alkaline proteases and cellulase are produced by a number of microorganisms, but
limited research was done on bulk production of alkaline proteases and cellulases by alkali‐
philic actinomycetes. Cellulases and proteases are the most wanted extracellular enzymes
and constitute 60% of global enzymes sales [53]. Reports claimed that a certain number of
alkaliphilic and halophilic actinomycetes produce extracellular protease enzymes [54]. The
halophilic protease secreted by the Nocardiopsis prasina HA-4 withstands a wide range of pH
(7–10) and temperature (20–42°C). Nocardiopsis halotolerans and Saccharomonospora halophila
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recovered from Kuwait showed better keratinolytic activity under high salt concentration
[55]. Streptomyces psammoticus that secreted lignin degrading enzymes under alkaline condi‐
tions confirmed that the enzymes have applications in delignification of pulp, textile dye de‐
colorization, and effluent treatment [53]. Cellulases are mainly involved in the production of
second-generation bioethanol and textile processing industry [56]. Halophilic cellulases ob‐
tained from actinomycetes and from metagenomic library of some marine bacteria were re‐
ported to be halostable, thermostable, and alkalostable, all favorable for textile and laundry
industries [57].
13. Advantage of using halophilic actinomycetes in the industry
Halophilic actinomycetes were suitable candidates for the expression of soluble recombinant
proteins [58]. A broad range of plasmid vectors obtained from halophilic actinomycetes are
used for cloning native promoters and heterologous promoters for the stable expression of
gene for the production of the industrially important, compatible solute ectoine [59]. Since
halophilic actinomycetes have antimicrobial activity and other extracellular enzymes pro‐
duction capability, there is less chance of contamination during fermentation. Therefore, the
major cost for the sterilization of the cultivation media is reduced.
14. Conclusions and future prospects
Several halophilic actinomycetes have special biological and chemical defense systems such
as pH tolerance, and stress-tolerant metals present one of the main sources for the discovery
of novel metabolites, biosurfactants, several other chemicals, and commercially important
enzymes with various applications. Despite the huge demand of synthetic molecules with
effective antimicrobial properties, novel methods and technologies for discovering novel
natural products from microbial sources from halophilic regions should be studied. The an‐
timicrobial metabolites producing novel actinomycetes are good bugs for unsterile cultiva‐
tion and continuous bioprocessing using seawater and low-cost-contributing media
components. It will be interesting to identify the mechanism of the stable properties of halo‐
philic enzymes, which may lead to significant novel biotechnological applications. Addition‐
ally, the stability of recombinant vectors in harsh conditions such as high salt, multiple
metal ions, or organic solvents should be investigated. In conclusion, halophilic actinomy‐
cetes will be a useful host for the production of commodity chemicals, antibiotics, enzymes,
and biofuels in bulk with low cost.
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